Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: J Steroid Biochem Mol Biol. 2010 Nov 16;125(1-2):95–104. doi: 10.1016/j.jsbmb.2010.11.004

Figure 2.

Figure 2

Chemical structures of representative AKR1C3 inhibitors and their inhibitory potency towards AKR1C3 and closely related isoforms AKR1C1 and AKR1C2.ND, not determined; CBM, 4-chlorobenzoyl melatonin; MPA, medroxyprogesterone acetate. The A- and B-rings of flufenamic acid are indicated.